Drug Type Small molecule drug |
Synonyms |
Mechanism MEK3 inhibitors(mitogen-activated protein kinase kinase 3 inhibitors), SIRT1 inhibitors(NAD-dependent deacetylase sirtuin 1 inhibitors), TAK1 subfamily inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18O4 |
InChIKeyOYJBHGSSAJNKJF-CQSZACIVSA-N |
CAS Registry2767124-77-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatitis | Preclinical | CN | 06 Aug 2022 | |
Colitis, Ulcerative | Preclinical | CN | 20 Apr 2022 |